Smaller regional volumes of brain gray and white matter demonstrated in breat cancer survivors exposed to adjuvant chemotherapy

Cancer

Volumn 109, Issue 1, 2007, Pages 146-156

  Inagaki, Masatoshi ^a   Yoshikawa, Eisho ^b   Matsuoka, Yutaka ^c   Sugawara, Yuriko ^d   Nakano, Tomohito ^e   Akechi, Tatsuo ^f   Wada, Noriaki ^a   Imoto, Shigeru ^a   Murakami, Koji ^g   Uchitomi, Yosuke ^a   Kobayakawa, Makoto ^h   Akizuki, Nobuya ^a   Fujimori, Maiko ^a  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b SHIZUOKA CANCER CENTER   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^d TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e KITASATO INSTITUTE HOSPITAL   (Japan)

^f NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^g DOKKYO MEDICAL UNIVERSITY   (Japan)

^h HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adjuvant chemotherapy; Breast cancer; Magnetic resonance imaging; Regional brain volume; Voxel based morphometry

Indexed keywords

CARMOFUR; CYCLOPHOSPHAMIDE; DOXIFLURIDINE; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; UFT;

ADULT; ARTICLE; ATTENTION; BRAIN SIZE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVOR; COGNITIVE DEFECT; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MENTAL CONCENTRATION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PREFRONTAL CORTEX; PRIORITY JOURNAL; SUBICULUM; VERBAL MEMORY; VISUAL MEMORY; WHITE MATTER;

ADOLESCENT; ADULT; BRAIN; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; COGNITION DISORDERS; FEMALE; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; ORGAN SIZE; PARAHIPPOCAMPAL GYRUS; PREFRONTAL CORTEX; TIME FACTORS;

EID: 33846312508     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.22368     Document Type: Article

References (37)

1. Phillips KA, Bernhard J. Adjuvant breast cancer treatment and cognitive function: current knowledge and research directions. J Natl Cancer Inst. 2003;95:190-197.
2. Wefel JS, Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma? A prologue. Cancer. 2004;101:466-475.
3. Jansen CE, Miaskowski C, Dodd M, Dowling G, Kramer J. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function. Cancer. 2005;104:2222-2233.
4. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with breast cancer: a meta-analysis of the current literature. Brain Cogn. 2005; 59:60-70.
5. Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE. Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc. 2003;9:967-982.
6. Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer. 2005;12:279-287.
7. Tuxen MK, Hansen SW. Neurotoxicity secondary to antineoplastic drugs. Cancer Treat Rev. 1994;20:191-214.
8. Troy L, McFarland K, Littman-Power S, et al. Cisplatin-based therapy: a neurological and neuropsychological review. Psychooncology. 2000;9:29-39.
9. Choi SM, Lee SH, Yang YS, Kim BC, Kim MK, Cho KH. 5-fluorouracil-induced leukoencephalopathy in patients with breast cancer. J Korean Med Sci. 2001;16:328-334.
10. Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemotherapy-induced cognitive disorders: neuropsychological, pathophysiological, and neuroimaging perspectives. Semin Clin Neuropsychiatry. 2003;8:201-216.
11. Rugo HS, Ahles T. The impact of adjuvant therapy for breast cancer on cognitive function: current evidence and directions for research. Semin Oncol. 2003;30:749-762.
12. Madhyastha S, Somayaji SN, Rao MS, Nalini K, Bairy KL. Hippocampal brain amines in methotrexate-induced learning and memory deficit. Can J Physiol Pharmacol. 2002;80: 1076-1084.
13. van der Kooy D, Zito KA, Roberts DC. Evidence on the retrograde neurotoxicity of doxorubicin. Neurosci Lett. 1985; 53:215-219.
14. Rzeski W, Pruskil S, Macke A, et al. Anticancer agents are potent neurotoxins in vitro and in vivo. Ann Neurol. 2004; 56:351-360.
15. Joshi G, Sultana R, Tangpong J, et al. Free radical mediated oxidative stress and toxic side effects in brain induced by the and cancer drug adriamycin: insight into chemobrain. Free Radic Res. 2005;39:1147-1154.
16. Yoshikawa E, Matsuoka Y, Inagaki M, et al. No adverse effects of adjuvant chemotherapy on hippocampal volume in Japanese breast cancer survivors. Breast Cancer Res Treat. 2005;92:81-84.
17. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol. 2002;20:485-493.
18. Fan HG, Houede-Tchen N, Yi QL, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol. 2005;23: 8025-8032.
19. Schagen SB, Muller MJ, Boogerd W, et al. Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients. Ann Oncol. 2002;13:1387-1397.
20. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial. Cancer. 2004;100:2292-2299.
21. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
22. Mori E, Mitani Y, Yamadori A. [Usefulness of a Japanese version of the Mini-Mental State in neurological patients]. (Japanese). Shinkeishinrigaku. 1985;1:82-90.
23. Sapolsky RM. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry. 2000;57: 925-935.
24. Wechsler D. Wechsler Memory Scale-Revised. New York: Psychological Corp; 1987.
25. Sugishita M. Wechsler Memory Scale-Revised (Japanese). Tokyo: Nihonbunkakagakusya; 2001.
26. Omura K, Sugishita M. Simultaneous confirmatory factor analysis of the Wechsler memory scale - revised for two standardization samples: a comparison of groups from Japan and the United States. J Clin Exp Neuropsychol. 2004; 26:645-652.
27. Ashburner J, Friston KJ. Voxel-based morphometry-the methods. Neuroimage. 2000;11(6 pt 1):805-821.
28. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage. 2001;14(1 pt 1):21-36.
29. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. Cerebral asymmetry and the effects of sex and handedness on brain structure: a voxel-based morphometric analysis of 465 normal adult human brains. Neuroimage. 2001;14:685-700.
30. Ashburner J, Neelin P, Collins DL, Evans A, Friston K. Incorporating prior knowledge into image registration. Neuroimage. Nov 1997;6:344-352.
31. 35w?>Ashburner J, Friston KJ. Nonlinear spatial normalization using basis functions. Hum Brain Mapp. 1999;7:254-266.
32. Worsley KJ, Marrett S, Neelin P, Vandal AC, Friston KJ, Evans AC. A unified statistical approach for determining significant voxels in images of cerebral activation. Hum Brain Mapp. 1996;4:58-73.
33. Friston KJ, Holmes A, Poline JB, Price CJ, Frith CD. Detect ing activations in PET and fMRI: levels of inference and power. Neuroimage. Dec 1996;4(3 pt 1):223-235.
34. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nat Rev Neurosci. 2002;3:243-249.
35. Petrides M. Mapping prefrontal cortical systems for the control of cognition. In: Toga AW, Mazziotta JC, eds. Brain mapping: the systems. 1st ed. New York Academic Press; 2000:159-176.
36. Witter MP, Wouterlood F. Parahippocampal region: organization and role in cognitive functions. New York and London: Oxford University Press; 2002.
37. Cavanna AE, Trimble MR. The precuneus: a review of its functional anatomy and behavioural correlates. Brain. 2006;129(pt 3):564-583.